ArticleInternational journal of molecular sciences2022

Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.

Paulina Chałupnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.